Phase Iii Study To Evaluate The Efficacy And Safety Of Glsi-100 (Gp2 + Gm-Csf) In Breast Cancer Patients With Residual Disease Or High-Risk Pcr After Both Neo-Adjuvant And Postoperative Adjuvant Anti-Her2 Therapy, Flamingo-01
Glsi-100
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase Iii Study To Evaluate The Efficacy And Safety Of Glsi-100 (Gp2 + Gm-Csf) In Breast Cancer Patients With Residual Disease Or High-Risk Pcr After Both Neo-Adjuvant And Postoperative Adjuvant Anti-Her2 Therapy, Flamingo-01 ### Output: Glsi-100